Search Results for ''

published presentations and documents on DocSlides.

Vision for Clinical Trials and Clinical Trials Units in the Future
Vision for Clinical Trials and Clinical Trials Units in the Future
by belinda
Professor Julia . Brown. Leeds Institute of Clinic...
Optimizing Mobile Clinical Trials by Engaging Patients and Sites
Optimizing Mobile Clinical Trials by Engaging Patients and Sites
by mia
Leanne Madre, CTTI . Cindy Geoghegan, Individual P...
Clinical Trials: Barriers, Facilitators & Mediators
Clinical Trials: Barriers, Facilitators & Mediators
by kellen
Lupus Conversations Clinical Trials Popular Opinio...
A PRACTICAL GUIDE TO RANDOMIZATION IN CLINICAL TRIALS
A PRACTICAL GUIDE TO RANDOMIZATION IN CLINICAL TRIALS
by susan
Why it Matters, How it Affects Power and How to Ge...
The Role of Clinical Trials Units
The Role of Clinical Trials Units
by edolie
Helen Hill. Senior Regional Advisor Clinical Trial...
Lesson 3: Clinical Trials
Lesson 3: Clinical Trials
by margaret
Module 3: The Basics of Health Care. Oncology Pati...
European & Developing Countries Clinical Trials Partnership (EDCTP)
European & Developing Countries Clinical Trials Partnership (EDCTP)
by karlyn-bohler
Towards EDCTP2. 22 July 2014. Melbourne, Australi...
Medicare Qualifying/Deemed Trials: What You Need to Know
Medicare Qualifying/Deemed Trials: What You Need to Know
by tatiana-dople
Theresa M. Shalaby, MSN, RN, CCRP. Manager, Clini...
Airspace Change Process & Airspace Trials in the contex
Airspace Change Process & Airspace Trials in the contex
by myesha-ticknor
Modernising. UK Airspace. Darren Rhodes. Civil A...
Fiery Trials & the will of God
Fiery Trials & the will of God
by alida-meadow
1 Peter 4:12—19 . In your . trials. believer, ...
Medicare Qualifying/Deemed Trials: What You Need to Know
Medicare Qualifying/Deemed Trials: What You Need to Know
by sherrill-nordquist
Theresa M. Shalaby, MSN, RN, CCRP. Manager, Clini...
Trial Design Issues for Phase II Trials
Trial Design Issues for Phase II Trials
by audrey
Guide to Two-Stage . IIa. Designs and . IIa. /IIb...
Practical Guide to Sequential Design
Practical Guide to Sequential Design
by megan
Primer on Sequential Design Methods . and Design C...
Introduction to CTTI Annemarie Forrest
Introduction to CTTI Annemarie Forrest
by tremblay
Public-Private Partnership. Co-founded by Duke Uni...
Implementation gap: how long have we known that interventions work
Implementation gap: how long have we known that interventions work
by nicole
Simon Gilbody . Professor of Psychological Medicin...
2020 Trends In Biostatistics
2020 Trends In Biostatistics
by harper
What you should know about study design. Demonstra...
Clinical Trials generalities
Clinical Trials generalities
by candy
& . specificities. for epidemic diseases in LM...
Crossover & Cluster Randomized Trials
Crossover & Cluster Randomized Trials
by tracy
Alternative Study Designs and Randomization Scheme...
Inclusion of Older Adults in Clinical Research: Why Multiple Chronic Conditions Matters
Inclusion of Older Adults in Clinical Research: Why Multiple Chronic Conditions Matters
by FoxyLady
Cynthia M. Boyd, MD, MPH. Professor of Medicine. E...
ITN TrialShare:   Promoting reproducible research and transparency in clinical trials
ITN TrialShare: Promoting reproducible research and transparency in clinical trials
by jade
Adam Asare, PhD. Director, Data Analysis . 12/11/2...
Developing Better Medicines at Lower
Developing Better Medicines at Lower
by luanne-stotts
Costs: The . Good Pharma Model. Speaker:. Donald ...
MAKING PRAGMATIC TRIALS WORK
MAKING PRAGMATIC TRIALS WORK
by giovanna-bartolotta
operational challenges & . decision support t...
Mock Trials  Outreach and Community Involvement
Mock Trials Outreach and Community Involvement
by olivia-moreira
Benefits. Preparation. Material Selection. Conduc...
Clinical Trial Protocol & Amendments
Clinical Trial Protocol & Amendments
by liane-varnes
William Petros, PharmD, FCCP. Professor, Schools ...
Developing Better Medicines at Lower
Developing Better Medicines at Lower
by tatiana-dople
Costs: The . Good Pharma Model. Speaker:. Donald ...
How public involvement work is valued by Chief Investigat
How public involvement work is valued by Chief Investigat
by giovanna-bartolotta
Prof Carrol Gamble. Dept. Biostatistics. Univers...
Antidepressants & the Politics of Health
Antidepressants & the Politics of Health
by mitsue-stanley
David Healy. All Trials. GSK. House of Common. A...
Why Do
Why Do
by briana-ranney
W. e . H. ave Adversity?. Adversity. Life would b...
California’s Pierce’s
California’s Pierce’s
by test
Disease Control . Program. Bob Wynn. Statewide Co...
A  Community Perspective on SMART
A Community Perspective on SMART
by test
Richard Jefferys. Coordinator, Michael . Palm Bas...
Clinical Trials and Testing of Veterinary Medicinal Products in Ireland
Clinical Trials and Testing of Veterinary Medicinal Products in Ireland
by jesiah
Jane Lenehan, Scientific Animal Protection Manager...
UCSF 9 th  Annual Gyn Cancer Symposium
UCSF 9 th Annual Gyn Cancer Symposium
by lucy
Clinical Trials: What to expect on a clinical tria...
PipShield: Hatcher  Microbial Solution
PipShield: Hatcher Microbial Solution
by yvonne
The Hatching process |. Harsh chemicals are routin...
COVID-19  Clinical Trials Review
COVID-19 Clinical Trials Review
by tremblay
Committee. Committee Overview & Process for In...
Oncology Clinical Trials
Oncology Clinical Trials
by holly
Sylvia . O’Neill, . MD . Executive Di...
Non-inferiority And Equivalence
Non-inferiority And Equivalence
by delilah
Design considerations and sample size. Demonstrate...
Sample  SIZe  for  Non-INFERIORITY Studies
Sample SIZe for Non-INFERIORITY Studies
by bety
Design and Endpoint Considerations. Demonstrated o...